FI20000780A0 - Oral drug form for controlled release of drug - Google Patents

Oral drug form for controlled release of drug

Info

Publication number
FI20000780A0
FI20000780A0 FI20000780A FI20000780A FI20000780A0 FI 20000780 A0 FI20000780 A0 FI 20000780A0 FI 20000780 A FI20000780 A FI 20000780A FI 20000780 A FI20000780 A FI 20000780A FI 20000780 A0 FI20000780 A0 FI 20000780A0
Authority
FI
Finland
Prior art keywords
drug
controlled release
oral
oral drug
drug form
Prior art date
Application number
FI20000780A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20000780A (en
Inventor
Martti Marvola
Mia Saekkinen
Original Assignee
Novasso Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novasso Oy filed Critical Novasso Oy
Priority to FI20000780A priority Critical patent/FI20000780A/en
Publication of FI20000780A0 publication Critical patent/FI20000780A0/en
Priority to PCT/FI2001/000322 priority patent/WO2001076562A1/en
Priority to AU2001252296A priority patent/AU2001252296A1/en
Publication of FI20000780A publication Critical patent/FI20000780A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI20000780A 2000-04-03 2000-04-03 Oral dosage form for controlled release of the drug FI20000780A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FI20000780A FI20000780A (en) 2000-04-03 2000-04-03 Oral dosage form for controlled release of the drug
PCT/FI2001/000322 WO2001076562A1 (en) 2000-04-03 2001-04-03 A peroral pharmaceutical formulation for controlled release of a drug
AU2001252296A AU2001252296A1 (en) 2000-04-03 2001-04-03 A peroral pharmaceutical formulation for controlled release of a drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20000780A FI20000780A (en) 2000-04-03 2000-04-03 Oral dosage form for controlled release of the drug

Publications (2)

Publication Number Publication Date
FI20000780A0 true FI20000780A0 (en) 2000-04-03
FI20000780A FI20000780A (en) 2001-10-04

Family

ID=8558105

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20000780A FI20000780A (en) 2000-04-03 2000-04-03 Oral dosage form for controlled release of the drug

Country Status (3)

Country Link
AU (1) AU2001252296A1 (en)
FI (1) FI20000780A (en)
WO (1) WO2001076562A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ548844A (en) * 2004-01-06 2011-03-31 Panacea Biotec Ltd Controlled release pharmaceutical composition comprising an acid-insoluble polymer and bioadhesive polymer
FI116625B (en) 2004-01-28 2006-01-13 Macrocrystal Oy Process for crystallization of proteins with carbohydrate-derived polymers
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
JP2011511782A (en) 2008-02-12 2011-04-14 アボット・ラボラトリーズ Extended release hydrocodone acetaminophen and related methods and uses
HUE036187T2 (en) 2012-04-30 2018-06-28 Tillotts Pharma Ag A delayed release drug formulation
UA117260C2 (en) 2013-10-29 2018-07-10 Тиллоттс Фарма АГ A delayed release drug formulation
EP3409688A1 (en) 2017-05-31 2018-12-05 Tillotts Pharma Ag Topical treatment of inflammatory bowel disease using anti-tnf-alpha antibodies and fragments thereof
EP3459527B1 (en) 2017-09-20 2022-11-23 Tillotts Pharma Ag Method for preparing a solid dosage form comprising antibodies by wet granulation, extrusion and spheronization
EP3459529A1 (en) 2017-09-20 2019-03-27 Tillotts Pharma Ag Preparation of sustained release solid dosage forms comprising antibodies by spray drying
EP3459528B1 (en) 2017-09-20 2022-11-23 Tillotts Pharma Ag Preparation of solid dosage forms comprising antibodies by solution/suspension layering
WO2020114616A1 (en) 2018-12-07 2020-06-11 Tillotts Pharma Ag Topical treatment of immune checkpoint inhibitor induced diarrhoea, colitis or enterocolitis using antibodies and fragments thereof
EP3662900A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation
EP3662901A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Delayed release drug formulation comprising an outerlayer with an enzymaticyaaly degradable polymer, its composition and its method of manufacturing
EP3662898A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine
EP3662902A1 (en) 2018-12-07 2020-06-10 Tillotts Pharma AG Colonic drug delivery formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0813748B2 (en) * 1990-04-23 1996-02-14 帝國製薬株式会社 Colon disintegrating polypeptide oral preparation
US5830883A (en) * 1995-11-06 1998-11-03 Duquesne University Of The Holy Ghost Methods of creating a unique chitosan and employing the same to form complexes with drugs, delivery of the same within a patient and a related dosage form
ES2217797T3 (en) * 1998-08-14 2004-11-01 F. Hoffmann-La Roche Ag HETEROCICLIC VINYLETERS AGAINST NEUROLOGICAL DISORDERS.

Also Published As

Publication number Publication date
FI20000780A (en) 2001-10-04
AU2001252296A1 (en) 2001-10-23
WO2001076562A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
DK1674084T3 (en) Prolonged release of oral dosage composition
FI20000572A (en) Device intended for application of implants
DK1158992T3 (en) Use of xenon for the preparation of a pharmaceutical composition for the treatment of neurointoxins
DE69936002D1 (en) ADJUSTED SPOON FOR ORAL MEDICAMENT ADMINISTRATION
EE200000383A (en) Oral pharmaceutical extended release dosage form
NO20014035D0 (en) Oral drug administration system
FR2804025B1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS
NO20030713D0 (en) Oral solid dose vaccine
NO20022970L (en) Hydrogel-driven drug dosage form
FI20000780A0 (en) Oral drug form for controlled release of drug
NO20033343L (en) Pharmaceutical dosage forms of epothilones for oral administration
AR026045A1 (en) FORMULATIONS OF PROLONGED RELEASE OF ERYTHROMOCINE DERIVATIVES
NO20030627D0 (en) Hydrogel-driven drug dosage form
FR2806903B1 (en) DENTAL PROSTHESIS
FI4823U1 (en) Modified release drug formulation
NO20021834D0 (en) Oral formulations of anti-tumor compounds
IS7481A (en) Epothilone for oral administration
PT1136081E (en) CONTROLLED LIBERATION COMPOSITIONS FOR PARENTERIC ADMINISTRATION OF MICROLIDS
NO20041383L (en) Flash melt oral dosage formulation
NO20025394D0 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
DK1150681T3 (en) Use of a pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
HUP0204417A3 (en) Oral ciprofloxacin-composition of controlled release
NO20021452L (en) Oral controlled release formulations
NO20043007L (en) Pharmaceutical suspension for oral administration
NO20043633L (en) Oral dosage form for controlled drug release